Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 High neonatal concentrations of raltegravir following transplacental transfer in HIV-1 positive pregnant women.

Literature DB >> 20827058

High neonatal concentrations of raltegravir following transplacental transfer in HIV-1 positive pregnant women.

Denise A McKeown, Melanie Rosenvinge, Sheila Donaghy, Mike Sharland, David W Holt, Ian Cormack, Phillip Hay, S Tariq Sadiq.

Abstract

Entities: Chemical Species

Mesh：

Substances：

Year: 2010 PMID： 20827058 DOI： 10.1097/QAD.0b013e32833d8a50

Source DB: PubMed Journal: AIDS ISSN： 0269-9370 Impact factor: 4.177

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

1. Pharmacokinetic and safety of raltegravir in pregnancy.

Authors: Leonardo Croci; Michele Trezzi; Maria Pia Allegri; Tiziana Carli; Silvia Chigiotti; Maria Piera Riccardi; Barbara Ricciardi; Mario Toti; Cesira Nencioni
Journal: Eur J Clin Pharmacol Date: 2012-03-01 Impact factor: 2.953

2. Salvage Regimens Containing Darunavir, Etravirine, Raltegravir, or Enfuvirtide in Highly Treatment-Experienced Perinatally Infected Pregnant Women.

Authors: Gail F Shust; Jennifer Jao; Gabriela Rodriguez-Caprio; Roberto Posada; Katherine T Chen; Amelia Averitt; Rhoda S Sperling
Journal: J Pediatric Infect Dis Soc Date: 2013-04-12 Impact factor: 3.164

3. Integrase inhibitors in late pregnancy and rapid HIV viral load reduction.

Authors: Lisa Rahangdale; Jordan Cates; JoNell Potter; Martina L Badell; Dominika Seidman; Emilly S Miller; Jenell S Coleman; Gweneth B Lazenby; Judy Levison; William R Short; Sigal Yawetz; Andrea Ciaranello; Elizabeth Livingston; Lunthita Duthely; Bassam H Rimawi; Jean R Anderson; Elizabeth M Stringer
Journal: Am J Obstet Gynecol Date: 2016-03 Impact factor: 8.661

4. Pharmacokinetics and Placental Transfer of Elvitegravir, Dolutegravir, and Other Antiretrovirals during Pregnancy.

Authors: Bassam H Rimawi; Erica Johnson; Augustine Rajakumar; Sijia Tao; Yong Jiang; Scott Gillespie; Raymond F Schinazi; Mark Mirochnick; Martina L Badell; Rana Chakraborty
Journal: Antimicrob Agents Chemother Date: 2017-05-24 Impact factor: 5.191

5. Raltegravir pharmacokinetics in neonates following maternal dosing.

Authors: Diana F Clarke; Edward P Acosta; Matthew L Rizk; Yvonne J Bryson; Stephen A Spector; Lynne M Mofenson; Edward Handelsman; Hedy Teppler; Carolee Welebob; Deborah Persaud; Mae P Cababasay; JiaJia Wang; Mark Mirochnick
Journal: J Acquir Immune Defic Syndr Date: 2014-11-01 Impact factor: 3.731

6. Raltegravir pharmacokinetics during pregnancy.

Authors: D Heather Watts; Alice Stek; Brookie M Best; Jiajia Wang; Edmund V Capparelli; Tim R Cressey; Francesca Aweeka; Patty Lizak; Regis Kreitchmann; Sandra K Burchett; David E Shapiro; Elizabeth Hawkins; Elizabeth Smith; Mark Mirochnick
Journal: J Acquir Immune Defic Syndr Date: 2014-12-01 Impact factor: 3.731

High neonatal concentrations of raltegravir following transplacental transfer in HIV-1 positive pregnant women.

1. Pharmacokinetic and safety of raltegravir in pregnancy.

2. Salvage Regimens Containing Darunavir, Etravirine, Raltegravir, or Enfuvirtide in Highly Treatment-Experienced Perinatally Infected Pregnant Women.

3. Integrase inhibitors in late pregnancy and rapid HIV viral load reduction.

4. Pharmacokinetics and Placental Transfer of Elvitegravir, Dolutegravir, and Other Antiretrovirals during Pregnancy.

5. Raltegravir pharmacokinetics in neonates following maternal dosing.

6. Raltegravir pharmacokinetics during pregnancy.

7. Short communication: Use of raltegravir in late-presenting HIV-infected pregnant women.

Review 8. Use of Integrase Inhibitors in HIV-Infected Children and Adolescents.

9. Bidirectional Transfer of Raltegravir in an Ex Vivo Human Cotyledon Perfusion Model.

Review 10. Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals.